Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 0.6210
+0.0010 (0.16%)
Feb 26, 2026, 5:29 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 211.64 million as of February 26, 2026. Its market cap has increased by 217.56% in one year.
Market Cap
211.64M
Enterprise Value
50.82M
Revenue
20.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.62
Market Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 211.64M, an increase of 146.69%. That is a compound annual growth rate of 10.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 211.64M | -32.79% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 308.69M |
| Mendus AB | 295.09M |
| Bio-Works Technologies AB | 294.30M |
| Lipum AB | 288.49M |
| Xintela AB | 241.15M |
| Sprint Bioscience AB | 234.24M |
| AlzeCure Pharma AB | 224.66M |
| Initiator Pharma | 215.63M |